1Park JA, Lee KY, Oh YJ, et al. Activation of caspase-3 protease via a Bcl - 2 - insensitive pathway during theprocess of ginsenoside Bh2 - induced apoptosis [J] . Cancer Lett , 1997 ,121 (1): 73-81.
2Efferth T, Davey M, Olbrich A, et al. Activity of Drugs from Traditional Chinese Medicine toward Sensitive and MDR1 - or MRP1 -Overexpressing Multidrug- Resistant Human CCRFCEM Leukemia Cells [ J ] . Blood Cells Mol Dis, 2002 , 28(2): 160-168.
3Kim HE, Oh JH, Lee SK, et al. Ginsenoside RH -2 induces apoptotic cell death in rat C6 glioma via a reactiveoxygen - and-caspase - dependent by Bcl - X (L) - independent pathway[J] . Life Sci , 1999, 65 (3) : PL33 -40.
4Jin YH, Yoo K J, Lee YH, et al. Caspase 3 - mediated cleavage of p21WAF1/CIP1 associated with the cyclinA -cyclin -dependent kinase 2 complex is a prerequisite for apoptosis in SKHEP-1 cells [J] .J Biol Chem, 2000, 275 (39): 30256- 30263.
5Kim ND, Kang SY and shcini Vb. Ginsenoside evoke endothilium- dependent vascular relation in rat aorta [J] . Gen pharmacool, 1994, 25: 1071.
6Fan ZH, Isobe K, Kjuchji K, et al. Enchancement of nitric oxide production from activated macrophages by a purified from ginsenoside (Rg1) [J] . Am J Chin Med , 1995, 23 (1) :279.
7Park YC, Lee CH, Kang HS, et al. Ginsenoside - Rh1 and Bh2 inhibit the induction of nitric oxide synthesis in murine peritoneal macrophages [J] .Biochem Mol Biol Int, 1996 , 40(4) : 751 -757.
8Nakata H,Kikuchi Y,Tode T,et al.Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells[J].Jpn J Cancer Res,1998,89 (7):733 -740.
9Kudo K,Tachikawa E,Kashimoto T,et al.Properties of ginseng saponin inhibition of catecholamine secretion in bovineadrenal chromaffin cells[J].Eur J Pharmacol,1998,341 (2 -3):139-144.
10Tode T,Kikuchi Y,Kita T,et al.Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice[J].J Cancer Res Clin Oncol,1993,120 (1-2):24-26.
2LIU Jing,ZHAO Zhong-zhen,CHEN Hu-biao School of Chinese Medicine,Hong Kong Baptist University,Hong Kong,China.Review of Astragali Radix[J].Chinese Herbal Medicines,2011,3(2):90-105. 被引量：12
3Gmberg BH, Bremnes RM, Fltten O, et al. Phase N[ study bythe Nor- wegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in ad- vanced non-small-cell lung cancer[J]. J Clin Oncol, 2009, 27(19) : 3217 - 3224.
4Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1 ) [ J]. Eur J Cancer, 2009, 45(2) : 228-247.
5Uramoto H, Onitsuka T, Shimokawa H, et al. TS DHFR and GARFT expression in non - squamous cell carcinoma of NSCLC and malignant pleural mesothelioma patients treated with pemetrexed [ J ]. Anticancer Res, 2010, 30(10) : 4309-4315.
6Grnberg BH,Bremnes RM,Fltten O,et al.PhaseⅢstudy bythe Norwegian lung cancer study group:pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer[J].J Clin Oncol,2009,27(19):3217-3224.
8Uramoto H,Onitsuka T,Shimokawa H,et al.TS DHFR and GARFTexpression in non-squamous cell carcinoma of NSCLC and malignant pleural mesothelioma patients treated with pemetrexed[J].Anticancer Res,2010,30(10):4309-4315.
